697739-04-1

Basic information

• Product Name: Methyl 3-aMino-5-fluoro-2-Methylbenzoate
• Synonyms: Methyl 3-aMino-5-fluoro-2-Methylbenzoate
• CAS NO: 697739-04-1
• Molecular Weight: 183.182
• Mol File: 697739-04-1.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Methyl 3-aMino-5-fluoro-2-Methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 3-aMino-5-fluoro-2-Methylbenzoate(697739-04-1)
• EPA Substance Registry System: Methyl 3-aMino-5-fluoro-2-Methylbenzoate(697739-04-1)

Safety Data

• Hazardous Substances Data: 697739-04-1(Hazardous Substances Data)

Usage

General Description

Methyl 3-amino-5-fluoro-2-methylbenzoate is a chemical compound with the formula C10H11NO2F. It is a derivative of benzoic acid and contains a fluorine atom and a methyl group attached to the benzene ring. Methyl 3-aMino-5-fluoro-2-Methylbenzoate is commonly used in pharmaceutical research and development as a building block in the synthesis of various drugs and drug candidates. It may also have biological activity and potential therapeutic applications, making it an important target for medicinal chemistry studies. Additionally, its unique structural features and reactivity make it a valuable tool for exploring new pathways for organic synthesis.

Upstream product

• 850462-64-5 5-fluoro-2-methyl-3-nitrobenzoic acid 
• 33184-16-6 5-fluoro-2-methylbenzoic acid 
• 697739-03-0 5-fluoro-2-methyl-3-nitrobenzoic acid methyl ester 

Downstream Products

• 697739-05-2 methyl 6-fluoro-1H-indazole-4-carboxylate 
• 1379341-19-1 methyl 3-chloro-5-fluoro-2-methylbenzoate 

Relevant articles and documents

Isoindoline compound, and preparation method, pharmaceutical composition and application thereof

The invention relates to a polysubstituted isoindoline compound represented by a general formula (I), and a preparation method, a pharmaceutical composition and an application thereof. Specifically, as a CRL4CRBNE3 ubiquitin ligase regulator with a novel structure, the polysubstituted isoindoline compound provided by the invention has stronger anti-tumor activity and an anti-tumor spectrum, and can be used for preparing medicines for treating diseases related to CRL4CRBNE3 ubiquitin ligase.

1-((S)-1-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)ETHYL)-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASES

The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containi

NOVEL BRADYKININ B2 RECEPTOR ANTAGONISTS

The invention relates to a compound according to general formula (I), which acts as a bradykinin (BK) B2 receptor antagonist; to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament.